Emanuel Iglesias Torres
Internal Medicine · Coto Laurel, PRNPI 1114215597
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AstraZeneca at 43.8% of the total. Among internal medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- PBG Puerto Rico LLC$480
- Johnson & Johnson$428
- E.r. Squibb & Sons, L.L.C.$407
- Boehringer Ingelheim$376
- Dexcom, Inc.$194
- plus $1K from 10 others
What the payments were for
- Food & beverage$5,147100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 99 | $2,261 |
| PBG Puerto Rico LLC | 24 | $480 |
| Johnson & Johnson | 14 | $428 |
| E.r. Squibb & Sons, L.L.C. | 12 | $407 |
| Boehringer Ingelheim | 18 | $376 |
| Dexcom, Inc. | 4 | $194 |
| Merck | 14 | $175 |
| Bayer Puerto Rico Inc. | 7 | $173 |
| AbbVie(2 entities) | 4 | $163 |
| GSK | 6 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $106 |
| Novo Nordisk | 4 | $81 |
| Sanofi-aventis U.S. LLC | 4 | $68 |
| Medtronic | 1 | $61 |
| Bayer | 2 | $52 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$114
- AVYCAZ$109
How this compares
$5,160 in reported general payments places this provider in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 121 | $86,996 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 80 | $66,717 |
| XareltoRivaroxaban | 71 | $58,914 |
| TradjentaLinagliptin | 64 | $49,685 |
| SynthroidLevothyroxine Sodium | 546 | $46,031 |
| EliquisApixaban | 46 | $35,628 |
| Xigduo XrDapaglifloz Propaned/Metformin | 42 | $33,375 |
| BrilintaTicagrelor | 50 | $27,214 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $25,292 |
| MounjaroTirzepatide | 24 | $25,071 |
| JardianceEmpagliflozin | 31 | $24,041 |
| JanuviaSitagliptin Phosphate | 27 | $23,487 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 27 | $20,966 |
| JentaduetoLinagliptin/Metformin Hcl | 18 | $19,978 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $19,813 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance, Trijardy Xr, Jentadueto, Synjardy Xr | $376 | $162,596210 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $2,261 | $120,742196 claims |
| MerckJanumet Xr, Januvia | $175 | $90,204107 claims |
| Johnson & JohnsonXarelto | $428 | $58,91471 claims |
| AbbVieSynthroid | $163 | $46,031546 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $113 | $45,10586 claims |
| Sanofi-aventis U.S. LLCLantus | $68 | $10,373107 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.
Other internal medicine in Coto Laurel
- Jorge Torres OlmedaCoto Laurel$23K
- Nelson VallejoLas Piedras$621K
- Ricardo FernandezSan Juan$351K
- Ronald Collazo PaganManati$206K
- Angel VinuelaDorado$182K
- Julio JimenezSan Lorenzo$99K
- Luis Negron GarciaSan German$24K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
- Luis Rivera ColonRio Piedras$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.